| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/20/1996 | WO1996018898A1 Multilayer analytical element |
| 06/20/1996 | WO1996018897A1 Separator float for blood collection tubes |
| 06/20/1996 | WO1996018893A1 Method for measurement of analytes by ion mobility spectrometry |
| 06/20/1996 | WO1996018887A1 Improved cell and circuit for monitoring photochemical reactions |
| 06/20/1996 | WO1996018878A1 Method for rapid and simultaneous analysis of nucleated red blood cells |
| 06/20/1996 | WO1996018739A1 Plant adenylosuccinate lyase and dna coding therefor |
| 06/20/1996 | WO1996018734A1 Production of recombinant secretory component |
| 06/20/1996 | WO1996018728A1 Chondrocyte cell-lines |
| 06/20/1996 | WO1996018725A1 Human tissue inhibitor of metalloproteinase-4 |
| 06/20/1996 | WO1996018650A1 Novel receptor |
| 06/20/1996 | WO1996018649A1 Improved cyclic crf agonists |
| 06/20/1996 | WO1996018648A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection |
| 06/20/1996 | WO1996018645A1 Peptides and synthetic cell membranes |
| 06/20/1996 | WO1996018642A1 Amino acids for making betides and methods of screening and making betide libraries |
| 06/20/1996 | WO1996018641A1 Modulators of the function of fas/apo1 receptors |
| 06/20/1996 | WO1996018639A1 Novel protein tyrosine kinase, jak3 |
| 06/20/1996 | WO1996018409A1 In vivo activation of tumor-specific cytotoxic t cells |
| 06/20/1996 | WO1996018336A2 Marker for individuals susceptible to alcoholism |
| 06/20/1996 | WO1996012809A3 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 06/20/1996 | WO1996012397A3 Recombinant antibody capable of binding to pna/nucleic acid complexes |
| 06/20/1996 | WO1996012018A3 Novel immunophilins and corresponding nucleic acids |
| 06/20/1996 | WO1996003993A3 Modulation of thymocyte and t cell functional activity |
| 06/20/1996 | DE4446695A1 Affinity viscometry hydrocolloid, e.g. for glucose determn. |
| 06/20/1996 | DE4446657A1 Diagnostic aid for differentiating between pathogenic and non-pathogenic amoeba |
| 06/20/1996 | DE4444893A1 Peptide und synthetische Zellmembranen Peptides and synthetic membranes |
| 06/20/1996 | DE4444764A1 Testset zur Analyse von Körperflüssigkeiten, Verfahren zu seiner Herstellung und Analyseverfahren A test kit for analyzing body fluids, to processes for its preparation and analytical methods |
| 06/20/1996 | DE4442002A1 Determn. of available carbon in waste-water treatment unit |
| 06/20/1996 | DE19546206A1 Coating esp. chemical plating process |
| 06/20/1996 | CA2207921A1 Novel receptor |
| 06/20/1996 | CA2207764A1 Chondrocyte cell-lines |
| 06/20/1996 | CA2207758A1 Device for performing one or more competitive immunoassays |
| 06/20/1996 | CA2207736A1 In vivo activation of tumor-specific cytotoxic t cells |
| 06/20/1996 | CA2207626A1 Novel protein tyrosine kinase, jak3 |
| 06/20/1996 | CA2207576A1 Improved cyclic crf agonists |
| 06/20/1996 | CA2207435A1 Combinatorial libraries having a predetermined frequency of each species of test compound |
| 06/20/1996 | CA2207326A1 Data recognition system |
| 06/20/1996 | CA2206669A1 Human tissue inhibitor of metalloproteinase-4 |
| 06/20/1996 | CA2206258A1 Amino acids for making betides and methods of screening and making betide libraries |
| 06/20/1996 | CA2205418A1 Plant adenylosuccinate lyase and dna coding therefor |
| 06/20/1996 | CA2202793A1 A test kit for analysing body fluids, a process for its production and an analysis method |
| 06/20/1996 | CA2177838A1 A methodology for selecting superagonists, antagonists and superantagonists of human interleukin-6 based on receptor complex three dimensional modelling |
| 06/20/1996 | CA2165522A1 Method and device for separating and measuring the volume of the various phases in fluid mixtures |
| 06/19/1996 | EP0717283A2 Device and test kit for the detection of AIDS |
| 06/19/1996 | EP0717282A2 Apparatus for determining foreign components in a gas stream |
| 06/19/1996 | EP0717112A1 Method and apparatus for testing MAI (Mycobacterium Avium-Intracellulare) for antibiotic sensitivity |
| 06/19/1996 | EP0717110A1 LGMD gene |
| 06/19/1996 | EP0717109A1 Synthetic DNA derived recombinant HIV-2 antigens |
| 06/19/1996 | EP0717108A1 Recombinant prrs proteins, diagnostic kits and vaccines containing said recombinant proteins |
| 06/19/1996 | EP0717104A2 Immunoassay of non-A, non-B hepatitis virus-related antigens, monoclonal antibodies for use therein, and hybridomas producing the antibodies |
| 06/19/1996 | EP0716746A1 Fluorescent oxygen channeling immunoassays |
| 06/19/1996 | EP0716745A1 Combination reagent holding and test device |
| 06/19/1996 | EP0716744A1 Bioactive porous partition members |
| 06/19/1996 | EP0716743A1 Method of detecting naphthylamines in mineral oils |
| 06/19/1996 | EP0716740A1 Method for activation of polyanionic fluorescent dyes in low dielectric media with quaternary onium compounds |
| 06/19/1996 | EP0716739A1 Fluid dose, flow and coagulation sensor for medical instrument |
| 06/19/1996 | EP0716738A1 Magnetic system for medical instrument |
| 06/19/1996 | EP0716737A1 Improved method and apparatus for aliquotting blood serum or blood plasma |
| 06/19/1996 | EP0716714A1 OLIGONUCLEOTIDES AND METHODS FOR THE DETECTION OF $i(CHLAMYDIA TRACHOMATIS) |
| 06/19/1996 | EP0716701A1 Cloning of a member of the serine-threonine-kinase family |
| 06/19/1996 | EP0716696A1 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease |
| 06/19/1996 | EP0716695A1 Human calcium channel compositions and methods using them |
| 06/19/1996 | EP0716662A1 Dna encoding prostaglandin receptor ep2 |
| 06/19/1996 | EP0716661A1 Pseudo- and non-peptide bradykinin receptor antagonists |
| 06/19/1996 | EP0716647A1 Hydrazino-type n 2?s 2? chelators |
| 06/19/1996 | EP0716623A1 Blood processing system having spill sensor with fail-safe circuit |
| 06/19/1996 | EP0716591A1 METHODS AND COMPOSITIONS FOR BINDING TAU AND MAP2c PROTEINS |
| 06/19/1996 | EP0524173B1 Solubilization and purification of the gastrin releasing peptide receptor |
| 06/19/1996 | EP0506923B1 A collagen binding protein as well as its preparation |
| 06/19/1996 | EP0504309B1 A well-tolerated, accurate, lower osmolar, oral glucose tolerance test |
| 06/19/1996 | EP0424397B1 Calcium channel compositions and methods |
| 06/19/1996 | CN1032088C Method and equipment for checking leaching resistance of material |
| 06/18/1996 | US5528521 Titration emulation system and method |
| 06/18/1996 | US5528366 Precision determination for molecular weights |
| 06/18/1996 | US5528225 An inactive to gas combustion, heat resistant, quadrivalent metallic oxide is mixed into sensitive section |
| 06/18/1996 | US5528155 Sensor for measuring material properties |
| 06/18/1996 | US5528133 Method and apparatus for determining the quality of a colloidal suspension |
| 06/18/1996 | US5528046 Method and device for determining the location and number of fluorescent molecules |
| 06/18/1996 | US5528036 Spectral detection of contaminants in containers |
| 06/18/1996 | US5527901 Tetrasaccharides bonding to a label, a chromatograpic support or protective group for isolating, purifying antibodies |
| 06/18/1996 | US5527896 Cloning by complementation and related processes |
| 06/18/1996 | US5527894 From contacting nucleic acid mixture with hiv-1 tat protein; partitioning, amplification |
| 06/18/1996 | US5527885 Useful for delivering drugs or radioisotopes to target organs, tumors or thrombi in vivo |
| 06/18/1996 | US5527884 Mediators of chronic allograft rejection and DNA molecules encoding them |
| 06/18/1996 | US5527843 Blend of gel material and thixotropic agent; viscosity |
| 06/18/1996 | US5527715 Reacting nonhydrolyzed urine sample with a polyclonal antibody(from animal immunized with hydrolyzed pyridinium conjugated to a carrier) yields measurable immunocomplex between antibody and pyrdinoline crosslinks in urine |
| 06/18/1996 | US5527714 Process for determining concentration of an analyte in a sample by antigen/antibody mediated particle agglutination in the presence of insoluble contaminats |
| 06/18/1996 | US5527713 Consisting of t-cell specific antibodies covalently bound to amine groups present on water soluble aminodextran |
| 06/18/1996 | US5527712 For specific procedures to detect specific binding partner molecules |
| 06/18/1996 | US5527711 Using a biotin-biotin binding protein interaction |
| 06/18/1996 | US5527710 Rate measurements of biomolecular reactions using electrochemiluminescence |
| 06/18/1996 | US5527709 Immunoassays with labeled thyronine hapten analogues |
| 06/18/1996 | US5527708 Measuring fluorescence from reaction of creatinine and 3,5-dinitrobenzoates or 3,5-dinitrobenzamide |
| 06/18/1996 | US5527703 Genetically engineered proteins for detection of channel modulators, insecticides, anthelmintics |
| 06/18/1996 | US5527686 Differential binding affinities and dissociation assays based thereon |
| 06/18/1996 | US5527684 Method of measuring the luminescence emitted in a luminescent assay |
| 06/18/1996 | US5527679 β5 protein and DNA encoding the same |
| 06/18/1996 | US5527676 Useful in cancer diagnostics |
| 06/18/1996 | US5527675 Method for degradation and sequencing of polymers which sequentially eliminate terminal residues |
| 06/18/1996 | US5527672 Hydrophobic coated membranes |
| 06/18/1996 | US5527666 Method for the diagnosis in vitro of HIV-1 virus infections |